Abstract
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare genetic arrhythmia predisposing to a high risk of sudden death during periods of adrenergic stress. The diagnosis hinges on the exercise stress test, which induces progressive polymorphic and bidirectional ventricular arrhythmias in affected patients. Genetic testing usually identifies a missense variant in the cardiac ryanodine receptor (RyR2). When arrhythmia symptoms are reported by patients, it is also common to perform a Holter monitor, which may identify ventricular arrhythmias.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.